CogState Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
CogState Ltd (CGS)
CogState Ltd stock price live, this page displays ASX CGS stock exchange data. View the CGS premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the CogState Ltd real time stock price chart below.
What Is the CogState Ltd Stock Price Today?
The CogState Ltd stock price today is 2.400.
What Is the Stock Symbol for CogState Ltd?
The stock symbol for CogState Ltd is ""CGS.""
What Stock Exchange Does CogState Ltd Trade On?
CogState Ltd is listed and trades on the Sydney stock exchange.
Is CogState Ltd a Good Stock to Buy?
Determining whether CogState Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CGS quote. (ISIN: AU000000CGS8)
What Is the CogState Ltd Stock Price Today?
The CogState Ltd stock price today is 2.400.
What Is the Stock Symbol for CogState Ltd?
The stock symbol for CogState Ltd is ""CGS.""
What Stock Exchange Does CogState Ltd Trade On?
CogState Ltd is listed and trades on the Sydney stock exchange.
Is CogState Ltd a Good Stock to Buy?
Determining whether CogState Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CGS quote. (ISIN: AU000000CGS8)
Sydney
Currency in AUD
2.400
+0.010(+0.42%)
Closed·
Fair Value
An estimate of a CogState Ltd's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.330
2.410
52 wk Range
0.860
2.490
CGS Scorecard
Full Analysis
Management has been aggressively buying back shares
CGS is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a CogState Ltd's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.3302.410
52 wk Range
0.8602.490
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.83%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.83%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
CGS Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a CogState Ltd's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
2.190
Downside
-8.75%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Holds more cash than debt on its balance sheet
- CogState Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro - CogState Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Cogstate PT receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Cogstate receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- CogState Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro - CogState Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Cogstate receives Investment Bank Analyst Rating Update
- Investing.com
Pro - CogState Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro - CogState Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
CogState Ltd Company Profile
Cogstate Limited, a neuroscience solutions company, engages in the creation, validation, and commercialization of digital brain health assessments worldwide. It offers digital cognitive assessment, endpoint data quality (rater services), remote assessment, scientific consulting, healthcare cognitive screening, and research and academic collaboration solutions for various therapeutic areas, including Alzheimer’s disease and dementia, preclinical Alzheimer’s disease, pediatrics and rare disease, Parkinson’s disease, multiple sclerosis, schizophrenia, oncology, safety, and sleep and mood disorders. The company also designs and provides quality assurance services in clinical trials focused on the administration, scoring, and recording of conventional brain health assessments. In addition, it develops a tool for primary care physicians and/or hospitals to assess cognitive decline. Its technology and associated services are used to quantify the effect of disease and drugs, devices, or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. The company serves biopharmaceutical companies, academic institutions, physicians, and patients. Cogstate Limited was incorporated in 1999 and is based in Melbourne, Australia.
Compare CGS to Peers and Sector
Metrics to compare | CGS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCGSPeersSector | |
|---|---|---|---|---|
P/E Ratio | 26.2x | 42.9x | −0.7x | |
PEG Ratio | 0.31 | 0.62 | 0.00 | |
Price/Book | 5.5x | 3.2x | 2.6x | |
Price / LTM Sales | 5.0x | 3.4x | 3.4x | |
Upside (Analyst Target) | −8.4% | 25.6% | 37.9% | |
Fair Value Upside | Unlock | 13.2% | 5.2% | Unlock |
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 2.190
(-8.75% Downside)
Earnings
Latest Release
Aug 21, 2025
EPS / Forecast
0.04 / --
Revenue / Forecast
29.15M / 35.95M
People Also Watch
FAQ
What Stock Exchange Does CogState Ltd Trade On?
CogState Ltd is listed and trades on the Sydney Stock Exchange stock exchange.
What Is the Stock Symbol for CogState Ltd?
The stock symbol for CogState Ltd is "CGS."
What Is the CogState Ltd Market Cap?
As of today, CogState Ltd market cap is 407.52M.
What Is CogState Ltd's Earnings Per Share (TTM)?
The CogState Ltd EPS (TTM) is 0.06.
When Is the Next CogState Ltd Earnings Date?
CogState Ltd will release its next earnings report on 02 Dec 2025.
From a Technical Analysis Perspective, Is CGS a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has CogState Ltd Stock Split?
CogState Ltd has split 3 times.
How Many Employees Does CogState Ltd Have?
CogState Ltd has 148 employees.
What is the current trading status of CogState Ltd (CGS)?
As of 13 Oct 2025, CogState Ltd (CGS) is trading at a price of 2.400, with a previous close of 2.39. The stock has fluctuated within a day range of 2.330 to 2.410, while its 52-week range spans from 0.860 to 2.490.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.